LakeShore Biopharma (LSB) has released an update.
LakeShore Biopharma has successfully regained compliance with Nasdaq’s minimum bid price requirement after its shares achieved a closing bid price of $1.00 or more for 11 consecutive days. This milestone resolves an earlier non-compliance issue and reflects positively on the company’s stock performance. Investors can now look forward to more stable trading conditions for the biopharmaceutical firm.
For further insights into LSB stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
